Research Based Relief

Clinical Research 

At Tennessee Valley Pain Consultants, our goal is to give our patients the best care possible. One of the ways we do this is through Clinical Research Trials. Clinical Trials give our patients another choice in their care that they would not have otherwise.

While on a Clinical Trial, patients receive one on one care with their research nurse and are followed closely by their physician. You will have a nurse assigned to you to be your point of contact for any questions or concerns that may arise and be there with you every step of the way.

What is a Clinical Trial?

A clinical trial is a medical treatment that seeks to determine if a medication is safe and effective; if it works better than other treatment options, if it is cost effective and what if any side effects it may cause. Patients who decide to participate in a trial sign an Informed Consent. An Informed Consent states the patient voluntarily agrees to be in the trial and that they fully understand what the trial is for and that all their questions have been answered. An informed Consent is not a contract and patients may withdraw from the study at any time with no penalty or it affecting their status in the doctor’s office.

What are some of the Benefits to the patient while being on a Clinical trial?

  • Most of the studies supply the study medication free of charge to the patient
  • Doctor office co-pays and visits, labs, EKG and other study related procedures are covered
  • Certain trials compensate patients for travel expenses including gas

Current & Previous Trials at TVPC:

CASCADE Study for Chronic Low Back Pain and Degenerative Disc Disease

http://www.CASCADEdddStudy.com 

Pain Management for Chronic Pain (Closed)
Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain
https://clinicaltrials.gov/ct2/show/study/NCT02603705?term=oc-eg-303&rank=1&show_locs=Y#locn

For Opioid Induced Constipation (Closed)
To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation
https://clinicaltrials.gov/ct2/show/NCT03060512?term=AstraZeneca+Phase+Iv&rank=1

 

For questions or to inquire about our site for future studies, please contact our Director of Research Jeffrey Dunlap, RN, BSN, CCRC at 256-265-7248 or via email at jeff@tnvalleypain.com